BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36754126)

  • 1. Increased 68 Ga-FAPI Activity in Benign Pulmonary Nodules.
    Su D; Li Z; Deng J; Qiu C; Chen Y
    Clin Nucl Med; 2023 May; 48(5):439-441. PubMed ID: 36754126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significantly Higher 68 Ga-FAPI Than 18 F-FDG Uptake by Hidradenocarcinoma of Head and Neck on PET/CT.
    Ding H; Wang Y; Liang J; Liu Y; Chen Y
    Clin Nucl Med; 2024 May; 49(5):466-467. PubMed ID: 38271244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography and computed tomography with [
    Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68 Ga-FAPI Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of Bone.
    Xu W; Cai J; Meng T; Pang Y; Chen H
    Clin Nucl Med; 2023 May; 48(5):460-462. PubMed ID: 36800246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased 68 Ga-FAPI Uptake in Benign Metastasizing Leiomyoma.
    Wu S; Cai J; Chen Q; Wu J; Chen H
    Clin Nucl Med; 2023 Sep; 48(9):809-811. PubMed ID: 37335290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 68 Ga-FAPI PET/CT in Screening Malignancy of Familial Adenomatous Polyposis.
    Erol Fenercioğlu Ö; Yarikkaya E; Beyhan E; Çermik TF; Ergül N
    Clin Nucl Med; 2023 Mar; 48(3):e141-e142. PubMed ID: 36240760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Cryptococcosis: Intense Uptake on Both 18 F-FDG and 68 Ga-FAPI PET/CT.
    Liu M; Liu H; Chen X; Zhang S; Cai L
    Clin Nucl Med; 2023 Nov; 48(11):980-981. PubMed ID: 37703455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential utility of [
    Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased 68 Ga-FAPI Activity in Hepatic Inflammatory Myofibroblastoma.
    Ou L; Zhou Y; Sun R; Zhang C; Chen X
    Clin Nucl Med; 2023 Jun; 48(6):522-524. PubMed ID: 37083628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68 Ga-FAPI-04 PET/CT in Selected Breast Cancer Patients With Low FDG Affinity : A Head-to-Head Comparative Study.
    Alçın G; Arslan E; Aksoy T; Cin M; Erol Fenercioğlu Ö; Beyhan E; Ergül N; Çermik TF
    Clin Nucl Med; 2023 Sep; 48(9):e420-e430. PubMed ID: 37351868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of 68Ga FAPI-04 and 18F-FDG PET/CT in Detecting Liver Metastases in Different Types of Cancer.
    Kaplan İ; Kepenek F; Güzel Y; Can C; Kömek H
    Nuklearmedizin; 2023 Aug; 62(4):252-259. PubMed ID: 37595623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of
    Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
    Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18 F-FDG and 68 Ga-FAPI-04 in the Evaluation of Aggressive Perivascular Epithelioid Cell Tumor.
    Zhang Z; Yu Y; Zhang L; Cheng C; Zuo C
    Clin Nucl Med; 2022 Oct; 47(10):897-899. PubMed ID: 35485860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved cancer detection in Waldeyer's tonsillar ring by
    Serfling S; Zhi Y; Schirbel A; Lindner T; Meyer T; Gerhard-Hartmann E; Lapa C; Hagen R; Hackenberg S; Buck AK; Scherzad A
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1178-1187. PubMed ID: 33057927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution, pharmacokinetics, dosimetry of [
    Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68 Ga-FAPI and 18 F-FDG Uptake in a Patient With Esophageal Candida Infection.
    Chen X; Liu M; Yang L; Shu Q; Cai L
    Clin Nucl Med; 2024 Jan; 49(1):83-85. PubMed ID: 37976435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.